Accretive Health (AH) Misses Q2 EPS by 5c

Accretive Health (NYSE: AH) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $236.7 million versus the consensus estimate of $234.64 million.

For earnings history and earnings-related data on Accretive Health (AH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Adamas Trust prices $90M senior notes offering at 9.600%
• Home Depot CEO takes medical leave 6 days before Q2 earnings